UNIGE document Scientific Article
previous document  unige:112122  next document
add to browser collection

Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function

Bonaventura, Aldo
Liberale, Luca
show hidden authors show all authors [1 - 13]
Published in International Journal of Cardiology. 2017, vol. 231, p. 1-5
Abstract Among endocannabinoid (EC)-related mediators, Oleoyl-ethanolamide (OEA) and Palmitoyl-ethanolamide (PEA), two endogenous PPARα agonists with lipolytic and anti-inflammatory action, respectively, are being actively investigated. Here, we assessed the potential association between plasma levels of PEA and OEA and coronary function in a cohort including normal, overweight, obese, and morbidly obese (MOB) individuals.
Keywords Biomarkers/bloodBody Mass IndexChromatography, LiquidCoronary Artery Disease/blood/diagnosis/etiologyCoronary Circulation/physiologyCoronary Vessels/diagnostic imaging/physiopathologyElectrocardiographyEnzyme-Linked Immunosorbent AssayEthanolamines/bloodHumansObesity/blood/complicationsPalmitic Acids/bloodPositron Emission Tomography Computed TomographyRegional Blood Flow/physiologyVasoconstriction/physiology
PMID: 27989579
Full text
Article (Published version) (247 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Toxicologie analytique et forensique (120)
(ISO format)
QUERCIOLI, Alessandra et al. Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function. In: International Journal of Cardiology, 2017, vol. 231, p. 1-5. https://archive-ouverte.unige.ch/unige:112122

18 hits

0 download


Deposited on : 2018-12-07

Export document
Format :
Citation style :